Phase 4 Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06241183 Sponsor: Stony Brook University Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Phase 4 Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT06241183
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with dyspepsia (indigestion)
  • People who arrive at the emergency department with upper abdominal pain rated at least 3 out of 10 on a pain scale

Who may not be able to join:

  • People who have a known allergy or sensitivity to any ingredient in Maalox, Mylanta, or Famotidine
  • People with moderate to severe kidney problems (confirm with trial site)
  • People with kidney failure
  • People who are pregnant or breastfeeding
  • People whose pain score is less than 3 out of 10
  • People who are unable to swallow or take oral (by mouth) medications
  • People who have a bowel obstruction (a blockage in the intestines)
  • People who have taken a proton pump inhibitor (a type of stomach acid medication) within 2 hours before receiving the study treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 6314447857

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Stony Brook University
Registry
ClinicalTrials.gov
Start date
9 November 2023
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Verbal Numerical Pain Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov